Cell Cycle Single Cell Rna Seq

Cell cycle single cell RNA sequencing (scRNA seq) enables researchers to infer the cell cycle phase (G1, S, G2, M) of each individual cell from its transcriptome. This guide is for computational biologists, bench scientists, and data analysts who study heterogeneous tissue samples and need to either control for cell cycle variation as a technical confound or harness it as a biological signal. We cover core concepts, decision points, a practical workflow, quality checks, common mistakes, and limits of interpretation, all grounded in authoritative sources.

Understanding cell cycle effects in scRNA seq is essential because proliferating cells express distinct gene sets depending on their phase, and this can either mask genuine biological variation or reveal functional states. For example, deep learning models now predict cell cycle phases from single cell RNAseq data with high accuracy [6]. The primary resource for learning the computational foundations is the EMBL EBI training materials, which cover data processing and analysis concepts [2].

At a Glance

Core Concepts: Cell Cycle Transcriptional Signatures

The cell cycle in mammalian cells is divided into interphase (G1, S, G2) and mitosis (M). Each phase is associated with a specific set of well characterized genes: histones and DNA replication factors in S phase, cyclins and cyclin dependent kinases in G2, and spindle assembly checkpoint regulators in M phase. Single cell RNA seq captures a snapshot of each cell, and computational methods compare expression levels of these signature genes to assign a phase or a score.

The NCBI Bookshelf provides an authoritative overview of cell cycle regulation at the molecular level [1]. For computational inference, the Galaxy Training Network offers step by step tutorials that explain how to score cells using reference gene lists [3]. A common approach is the Cyclone method, which uses a precompiled set of marker gene pairs to classify cells into G1, S, and G2M phases. More recent methods employ deep learning models trained on thousands of labeled cells to predict phase with higher resolution [6]. These tools are implemented in widely used R packages such as Seurat and Scran (via Bioconductor) [4].

Decision Points: When and How to Account for Cell Cycle

A critical choice in any scRNAseq analysis is whether to regress out cell cycle effects or retain them. The decision depends on your biological question:

• Regress out cell cycle if you are interested in cell type differences, disease signatures, or differentiation trajectories. Proliferating cells may cluster together otherwise, confounding your interpretation. Use the ScaleData function in Seurat with vars.to.regress = "S.Score" and "G2M.Score", or the scran::cyclone approach followed by regression.
• Keep cell cycle as a biological variable if you study proliferation, cell cycle arrest, or the effect of a treatment on cell cycle progression. In such cases, you can compare phase proportions between conditions or use the cell cycle score as a covariate in differential expression.
• Use cell cycle as a quality metric. Excessive fraction of cells in a single phase might indicate culture stress or a technical artifact. Check for consistency with known biology.

The Integrative single cell study of glioblastoma used cell cycle scoring to distinguish tumor cell subpopulations and their metabolic crosstalk [7]. Similarly, a pancreate cancer machine learning framework incorporated cell cycle associated fibroblast signatures to understand immune regulation [8]. These applications show that the choice to include or exclude cell cycle effects must align with the research goal.

Practical Workflow: Inferring and Handling Cell Cycle in scRNAseq

Implement a robust cell cycle analysis pipeline with the following steps based on Bioconductor best practices [4] and Galaxy training materials [3].

Step 1: Data Acquisition and Preprocessing

Obtain scRNAseq data from public repositories (e.g., NCBI SRA) or your project [5]. Perform standard quality control: filter low quality cells (high mitochondrial percentage, low gene count) and doublets. Normalize counts using log normalization or SCTransform.

Step 2: Feature Selection and Dimensionality Reduction

Identify highly variable genes. Run PCA to capture major sources of variation. At this stage, examine the PCA plot. If the first few PCs correlate strongly with cell cycle phase markers, cell cycle effects are prominent.

Step 3: Cell Cycle Scoring

Use a dedicated method. For R/Seurat: CellCycleScoring() with s.genes and g2m.genes arguments. For Python/Scanpy: use the sc.tl.score_genes_cell_cycle function. For a more refined approach, apply a deep learning model trained on cell cycle phases [6]. These models can output phase probabilities and are less reliant on arbitrary thresholds.

Step 4: Decision and Correction

Based on your goal, either regress out cell cycle scores or keep them. If regressing, apply linear regression normalization (Seurat: ScaleData) or use a modeling approach such as scran::rescaleBatches to remove phase batch effects.

Step 5: Downstream Analysis

Re run PCA and clustering. Compare cluster annotations with and without cell cycle regression. Check if previously prominent cell cycle driven clusters disappear or merge with biologically meaningful clusters. Continue with differential expression, trajectory inference, or cell type identification.

Step 6: Validation

Confirm that known markers of your cell types are not artificially removed. For example, a study of ovarian aging used single cell analysis to find a WT1 mediated axis in granulosa cells, which required careful cell cycle adjustment [10]. Similarly, retinal organoid research needed to separate cell cycle effects from photoreceptor pathology [11].

Quality Checks

Verify that your cell cycle inference is reliable.

• Check known marker expression: Plot expression of S phase markers (e.g., PCNA, MKI67, H2AFZ) across assigned phases. Ensure the pattern matches expectations. The single cell atlas of breast cancer studied UFSP2 involvement in spindle checkpoint, such validation is critical [9].
• PCA before vs after regression: Compare PC1/2. If PC1 formerly correlated with phase markers and no longer does after regression, the correction worked.
• Phase proportion consistency: Total cell cycle scores should be similar across clusters unless one cluster is truly more proliferative. An unbalanced distribution may indicate incomplete correction.
• Use multiple methods: Cyclone and Seurat scoring can give slightly different assignments, cross validate with a deep learning predictor [6].

Common Mistakes

• Regressing out biological signal: If your disease or experimental condition affects cell cycle, removing the effect can eliminate the very signal you want to study. Always test with and without regression.
• Using improper reference gene lists: Mouse gene lists do not always transfer to human, and neuronal cell cycle genes differ from proliferating lymphocytes. Use species and cell type appropriate lists.
• Assuming phase assignment equals exact time point: scRNAseq is a snapshot. A cell scored as G2 may be anywhere in a 4 hour window. Do not infer kinetic rates from phase frequencies without additional data.
• Over correcting with regression: Removing too much variation can distort lowly expressed genes or rare cell types. A mild correction or using a model with cell cycle as a covariate is often safer.
• Ignoring batch effects: Cell cycle scores can be confounded with experimental batches. Use integration methods (e.g., Harmony, FastMNN) that also account for cell cycle variation.

Limits of Interpretation

• No temporal resolution: scRNAseq cannot distinguish early vs late G1. Phase boundaries are continuous, assignment is probabilistic.
• Cell type specific signatures: Marker gene sets for cell cycle are often derived from HeLa or embryonic stem cells. They may not generalize to primary cells, adipocytes, or quiescent stem cells.
• Technical confounders: Dropout, library complexity, and sequencing depth can inflate or deflate phase scores. Use frameworks that incorporate uncertainty (e.g., deep learning) [6].
• Limited to a few phases: Standard methods only assign three phases (G1, S, G2M). More nuanced subphases require specialized algorithms or additional data (e.g., FUCCI reporters).
• Not a substitute for functional assays: Cell cycle inference from RNA alone cannot confirm cell cycle arrest or proliferation status, it only indicates transcriptional state.

Frequently Asked Questions

1. Can I use cell cycle scoring to identify proliferating cells in a tumor? Yes, but with caution. Cells in S/G2M are likely cycling, but some quiescent cells may express early G1 markers. Combine with proliferation markers like MKI67 for validation.

2. Should I regress out cell cycle before differential expression analysis? If you are comparing cell types between conditions and cell cycle is not your interest, yes. Always check that key differential genes are not cell cycle related.

3. What if my cells show no cell cycle score differences? Low cycling activity is common in terminally differentiated tissues (neurons, hepatocytes). If you expect proliferation, verify the quality of your data and the marker list.

4. Can cell cycle scoring introduce batch effects? If one batch contains more actively cycling cells due to culture conditions, yes. Use batch correction algorithms that preserve biological variability while regressing technical factors.

References and Further Reading

• NCBI Bookshelf. Cell cycle regulation overview. Available at: NCBI Bookshelf.
• EMBL EBI Training. scRNAseq analysis tutorials. Available at: EMBL EBI Training.
• Galaxy Training Network. Single cell RNA sequencing workflow. Available at: Galaxy Training Network.
• Bioconductor. SingleR and scran documentation. Available at: Bioconductor.
• NCBI Sequence Read Archive. Repository for raw sequencing data. Available at: NCBI SRA.
• Deep learning models for cell cycle phase prediction from single cell RNA sequencing data. Brief Bioinform. Available at: PubMed 42437449.
• Integrative single cell and spatial transcriptomic analysis reveals lactate driven crosstalk in glioblastoma. J Transl Med. Available at: PubMed 42436508.
• A single cell and machine learning framework identifies CAFs associated signatures in pancreatic cancer. J Gastrointest Oncol. Available at: PubMed 42434270.
• Exploring the potential involvement of UFSP2 in spindle assembly checkpoint regulation in breast cancer. Mol Biol Rep. Available at: PubMed 42430000.
• Single cell atlas reveals WT1 mediated axis in ovarian aging. Int J Mol Med. Available at: PubMed 42429048.

Related Articles

• Dna Replication
• Protein Synthesis
• Incomplete Dominance Gene
• Cell Membrane Function Biology
• Dna Structure